Literature DB >> 16189728

[The concept of frailty--from phenomenology to therapeutic approaches].

C C Sieber1.   

Abstract

Frailty--the weakness of many (oldest) old persons--induces a lot of human sorrow with functional disabilities as well as health-economic costs. Sarcopenia (loss of muscle mass) is also a form of frailty and a co-factor of two of the "geriatric Is"--immobility and instability. Pathophysiologically, both phenomena show signs of an inflammatory state. Physical activity and a healthy diet can partially reverse these health problems. Therefore, therapeutic strategies emerge to treat these frequent and clinically relevant phenomena.

Entities:  

Mesh:

Year:  2005        PMID: 16189728     DOI: 10.1007/s00391-005-1101-4

Source DB:  PubMed          Journal:  Z Gerontol Geriatr        ISSN: 0948-6704            Impact factor:   1.281


  25 in total

Review 1.  Aging of the human neuromuscular system.

Authors:  Anthony A Vandervoort
Journal:  Muscle Nerve       Date:  2002-01       Impact factor: 3.217

2.  Predictors of skeletal muscle mass in elderly men and women.

Authors:  R N Baumgartner; D L Waters; D Gallagher; J E Morley; P J Garry
Journal:  Mech Ageing Dev       Date:  1999-03-01       Impact factor: 5.432

3.  Sarcopenic obesity: the confluence of two epidemics.

Authors:  Ronenn Roubenoff
Journal:  Obes Res       Date:  2004-06

4.  Estimation in the positive stable shared frailty Cox proportional hazards model.

Authors:  Torben Martinussen; Christian B Pipper
Journal:  Lifetime Data Anal       Date:  2005-03       Impact factor: 1.588

5.  Antecedents of frailty over three decades in an older cohort.

Authors:  W J Strawbridge; S J Shema; J L Balfour; H R Higby; G A Kaplan
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  1998-01       Impact factor: 4.077

6.  Frailty in older adults: evidence for a phenotype.

Authors:  L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-03       Impact factor: 6.053

Review 7.  Functional and metabolic consequences of sarcopenia.

Authors:  W Evans
Journal:  J Nutr       Date:  1997-05       Impact factor: 4.798

Review 8.  Sarcopenia--consequences, mechanisms, and potential therapies.

Authors:  L J S Greenlund; K S Nair
Journal:  Mech Ageing Dev       Date:  2003-03       Impact factor: 5.432

9.  Insulin-like growth factor-1 and interleukin 6 predict sarcopenia in very old community-living men and women: the Framingham Heart Study.

Authors:  Hélène Payette; Ronenn Roubenoff; Paul F Jacques; Charles A Dinarello; Peter W F Wilson; Leslie W Abad; Tamara Harris
Journal:  J Am Geriatr Soc       Date:  2003-09       Impact factor: 5.562

10.  Serum levels of insulin-like growth factor-I (IGF-I) and dehydroepiandrosterone sulfate (DHEA-S), and their relationships with serum interleukin-6, in the geriatric syndrome of frailty.

Authors:  Sean X Leng; Anne R Cappola; Ross E Andersen; Marc R Blackman; Kathleen Koenig; Michael Blair; Jeremy D Walston
Journal:  Aging Clin Exp Res       Date:  2004-04       Impact factor: 3.636

View more
  2 in total

1.  The association of ABCB1 polymorphisms and elevated serum digitoxin concentrations in geriatric patients.

Authors:  Charalampos Dragonas; Jan T Wagner; Hans J Heppner; Thomas Bertsch; Wolfgang Muhlberg; Susanne Wicklein; Andreas Pahl; Christine Diewald; Iouri Bachmakov; Cornel C Sieber; Martin F Fromm
Journal:  Eur J Clin Pharmacol       Date:  2007-12-16       Impact factor: 2.953

2.  Alternative Exercise Technologies to Fight against Sarcopenia at Old Age: A Series of Studies and Review.

Authors:  Wolfgang Kemmler; Simon von Stengel
Journal:  J Aging Res       Date:  2012-02-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.